Annual EBITDA
-$429.14 M
+$137.41 M+24.25%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual earnings before interest, taxes, depreciation & amortization is currently -$429.14 million, with the most recent change of +$137.41 million (+24.25%) on 31 December 2023. During the last 3 years, it has fallen by -$314.70 million (-275.01%). BHVN annual EBITDA is now -4163.25% below its all-time high of -$10.07 million, reached on 31 December 2015.BHVN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$176.17 M
+$155.64 M+46.91%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly earnings before interest, taxes, depreciation & amortization is currently -$176.17 million, with the most recent change of +$155.64 million (+46.91%) on 30 September 2024. Over the past year, it has dropped by -$67.17 million (-61.61%). BHVN quarterly EBITDA is now -5801.98% below its all-time high of -$2.98 million, reached on 01 March 2016.BHVN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$841.60 M
-$67.17 M-8.67%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM earnings before interest, taxes, depreciation & amortization is currently -$841.60 million, with the most recent change of -$67.17 million (-8.67%) on 30 September 2024. Over the past year, it has dropped by -$351.21 million (-71.62%). BHVN TTM EBITDA is now -28094.41% below its all-time high of -$2.98 million, reached on 01 March 2016.BHVN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.3% | -61.6% | -71.6% |
| 3 y3 years | -275.0% | -251.0% | -698.0% |
| 5 y5 years | -87.8% | -28.2% | -72.2% |
BHVN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -275.0% | +24.3% | -251.0% | +46.9% | -698.0% | at low |
| 5 y | 5 years | -275.0% | +24.3% | -251.0% | +46.9% | -698.0% | at low |
| alltime | all time | -4163.3% | +24.3% | -5802.0% | +46.9% | <-9999.0% | at low |
Biohaven Pharmaceutical Holding EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$176.17 M(-46.9%) | -$841.60 M(+8.7%) |
| June 2024 | - | -$331.82 M(+82.5%) | -$774.44 M(+44.8%) |
| Mar 2024 | - | -$181.79 M(+19.7%) | -$534.80 M(+24.6%) |
| Dec 2023 | -$429.14 M(-24.3%) | -$151.82 M(+39.3%) | -$429.14 M(-12.5%) |
| Sept 2023 | - | -$109.01 M(+18.3%) | -$490.39 M(+9.3%) |
| June 2023 | - | -$92.18 M(+21.1%) | -$448.64 M(-18.9%) |
| Mar 2023 | - | -$76.13 M(-64.3%) | -$553.16 M(-2.4%) |
| Dec 2022 | -$566.55 M(+160.5%) | -$213.07 M(+216.8%) | -$566.55 M(+40.3%) |
| Sept 2022 | - | -$67.26 M(-65.8%) | -$403.68 M(+3.1%) |
| June 2022 | - | -$196.69 M(+119.7%) | -$391.68 M(+100.9%) |
| Mar 2022 | - | -$89.52 M(+78.3%) | -$194.99 M(+84.9%) |
| Dec 2021 | -$217.51 M(+90.1%) | - | - |
| Dec 2021 | - | -$50.20 M(-9.2%) | -$105.46 M(-55.1%) |
| Sept 2021 | - | -$55.27 M(-69.2%) | -$234.83 M(-64.6%) |
| Dec 2020 | -$114.43 M(-76.6%) | - | - |
| Dec 2020 | - | -$179.56 M(+8.4%) | -$663.44 M(+6.8%) |
| Sept 2020 | - | -$165.69 M(+3.4%) | -$621.34 M(+13.0%) |
| June 2020 | - | -$160.22 M(+1.4%) | -$549.80 M(-7.0%) |
| Mar 2020 | - | -$157.97 M(+14.9%) | -$591.47 M(+21.0%) |
| Dec 2019 | -$488.45 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$137.45 M(+46.0%) | -$488.89 M(+22.1%) |
| Sept 2019 | - | -$94.15 M(-53.4%) | -$400.40 M(+10.6%) |
| June 2019 | - | -$201.90 M(+264.6%) | -$361.89 M(+82.1%) |
| Mar 2019 | - | -$55.38 M(+13.1%) | -$198.73 M(-13.1%) |
| Dec 2018 | -$228.46 M(+81.1%) | - | - |
| Dec 2018 | - | -$48.96 M(-12.0%) | -$228.73 M(+10.3%) |
| Sept 2018 | - | -$55.65 M(+43.6%) | -$207.39 M(+6.7%) |
| June 2018 | - | -$38.74 M(-54.6%) | -$194.37 M(+0.6%) |
| Mar 2018 | - | -$85.38 M(+209.0%) | -$193.30 M(+53.2%) |
| Dec 2017 | -$126.18 M(+100.1%) | - | - |
| Dec 2017 | - | -$27.63 M(-35.2%) | -$126.18 M(+2.1%) |
| Sept 2017 | - | -$42.62 M(+13.1%) | -$123.64 M(+13.2%) |
| June 2017 | - | -$37.68 M(+106.4%) | -$109.18 M(+39.4%) |
| Mar 2017 | - | -$18.25 M(-27.2%) | -$78.32 M(+24.2%) |
| Dec 2016 | -$63.06 M(+526.5%) | - | - |
| Dec 2016 | - | -$25.09 M(-10.9%) | -$63.06 M(+66.1%) |
| Sept 2016 | - | -$28.17 M(+313.1%) | -$37.97 M(+287.3%) |
| June 2016 | - | -$6.82 M(+128.4%) | -$9.80 M(+228.4%) |
| Mar 2016 | - | -$2.98 M | -$2.98 M |
| Dec 2015 | -$10.07 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual EBITDA year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly EBITDA year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM EBITDA year-on-year change?
What is Biohaven Pharmaceutical Holding annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BHVN is -$429.14 M
What is the all time high annual EBITDA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.07 M
What is Biohaven Pharmaceutical Holding annual EBITDA year-on-year change?
Over the past year, BHVN annual earnings before interest, taxes, depreciation & amortization has changed by +$137.41 M (+24.25%)
What is Biohaven Pharmaceutical Holding quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BHVN is -$176.17 M
What is the all time high quarterly EBITDA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.98 M
What is Biohaven Pharmaceutical Holding quarterly EBITDA year-on-year change?
Over the past year, BHVN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$67.17 M (-61.61%)
What is Biohaven Pharmaceutical Holding TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BHVN is -$841.60 M
What is the all time high TTM EBITDA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.98 M
What is Biohaven Pharmaceutical Holding TTM EBITDA year-on-year change?
Over the past year, BHVN TTM earnings before interest, taxes, depreciation & amortization has changed by -$351.21 M (-71.62%)